Eric C. Olivares, Ph.D.
Affiliations: | 2003 | Stanford University, Palo Alto, CA |
Area:
Genetics, Molecular BiologyGoogle:
"Eric Olivares"Parents
Sign in to add mentor| Michele P. Calos | grad student | 2003 | Stanford | |
| (Phage integrases for gene therapy: From concept to application.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Flusberg BA, Webster DR, Lee JH, et al. (2010) Direct detection of DNA methylation during single-molecule, real-time sequencing. Nature Methods. 7: 461-5 |
| Keravala A, Lee S, Thyagarajan B, et al. (2009) Mutational derivatives of PhiC31 integrase with increased efficiency and specificity Molecular Therapy. 17: 112-120 |
| Chalberg TW, Portlock JL, Olivares EC, et al. (2006) Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48 |
| Bertoni C, Jarrahian S, Wheeler TM, et al. (2006) Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proceedings of the National Academy of Sciences of the United States of America. 103: 419-24 |
| Held PK, Olivares EC, Aguilar CP, et al. (2005) In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408 |
| Held PK, Olivares EC, Aguilar CP, et al. (2005) In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408 |
| Bertoni C, Jarrahian S, Wheeler TM, et al. (2005) 265. Enhanced Plasmid-Mediated Dystrophin Expression in the mdx Mouse Model for Duchenne Muscular Dystrophy by a PhiC31 Integrase Plasmid System Molecular Therapy. 11 |
| Portlock JL, Chalberg TW, Olivares EC, et al. (2005) 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11 |
| Quenneville SP, Chapdelaine P, Rousseau J, et al. (2004) Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts Molecular Therapy. 10: 679-687 |
| Chalberg TW, Ginsburg DS, Kirby PJ, et al. (2004) 814. Integration Sites Used by the PhiC31 Site-Specific Integrase in the Human Genome Molecular Therapy. 9 |